Two-stage, self-cycling process for the production of bacteriophages

Microbial Cell Factories

Volumn 9, Issue , 2010, Pages

  Sauvageau, Dominic ^a   Cooper, David G ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIOPHAGE; CELL SYNCHRONIZATION; CELL VOLUME; HOST CELL; INFECTION; NONHUMAN; CELL COUNT; ESCHERICHIA COLI; FERMENTATION; GROWTH, DEVELOPMENT AND AGING; METABOLISM;

BACTERIA (MICROORGANISMS);

CARBON DIOXIDE;

BACTERIOPHAGES; CARBON DIOXIDE; CELL COUNT; ESCHERICHIA COLI; FERMENTATION;

EID: 77958520726     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-9-81     Document Type: Article

References (59)

1. D'Herelle F. Sur un microbe invisible antagoniste des bacillus dysentériques. Comp Rend Acad Sci 1917, 165:373-375. [reprinted as On an invisible microbe antagonistic toward dysenteric bacilli: brief note by Mr F.D'Herelle, presented by Mr Roux. Res Microbiol 2007, 158:553-554].
2. Bruynoghe R, Maisin J. Essai de thérapeutique au moyen du bactériophage du Staphylocoque. Comp Rend Soc Biol 1921, 85:1120-1121.
3. D'Herelle F. Essai de traîtement de la peste bubonique par le bactériophage. Presse Médicale 1925, 33:1393-1394.
4. D'Herelle F, Malone RH, Lahiri M. Studies on Asiatic cholera. Ind Med Res Mem 1930, 14(1).
5. Sulakvelidze A, Vidze ZA, Morris G. Bacteriophage therapy. Antimicrob Agent Chemother 2001, 45:649-659.
6. Hanlon GW. Bacteriophages: an appraisal of their role in the treatment of bacterial infections. Int J Antimicrob Agents 2007, 30:118-128. 10.1016/j.ijantimicag.2007.04.006, 17566713.
7. Housby JN, Mann NH. Phage therapy. Drug Discov Today 2009, 14:536-540. 10.1016/j.drudis.2009.03.006, 19508915.
8. Kutter E. Phage therapy: bacteriophages as natural, self-replicating antimicrobials. Practical Handbook of Microbiology 2009, 713-730. Boca Raton: CRC Press, Goldman E, Green LH, 2.
9. Balasubramanian S, Sorokulova IB, Vodyanoy VJ, Simonian AL. Lytic phage as a specific and selective probe for detection of Staphylococcus aureus - A surface Plasmon resonance spectroscopy study. Biosens Bioelectron 2007, 22:948-955. 10.1016/j.bios.2006.04.003, 16697635.
10. Birmele M, Ripp S, Jegier P, Roberts MS, Sayler G, Garland J. Characterization and validation of a bioluminescent bioreporter for the direct detection of Escherichia coli. J Microbiol Methods 2008, 75:354-356. 10.1016/j.mimet.2008.06.003, 18593593.
11. Shen W, Lakshmanan RS, Mathison LC, Petrenko VA, Chin BA. Phage coated magnetoelastic micro-biosensors for real-time detection of Bacillus anthracis spores. Sensor Actuat B-Chem 2009, 137:501-506.
12. Withey S, Cartmell E, Avery LM, Stephenson T. Bacteriophages - potential for application in wastewater treatment process. Sci Total Environ 2005, 339:1-18. 10.1016/j.scitotenv.2004.09.021, 15740754.
13. Johnson RP, Gyles CL, Huff WE, Ojha S, Huff GR, Rath NC, Donoghue AM. Bacteriophages for prophylaxis and therapy in cattle, poultry and pigs. Anim Health Res Rev 2008, 9:201-215. 10.1017/S1466252308001576, 19102791.
14. Isnansetyo A, Istiqomah I, Sinansari S, Hernawan RK, Widada J. A potential bacterial biocontrol agent, strain S2V2 against pathogenic marine Vibrio in aquaculture. World J Microbiol Biotechnol 2009, 25:1103-1113.
15. Kocharunchitt C, Ross T, McNeil DL. Use of bacteriophages as biocontrol agents to control Salmonella associated with seed sprouts. Int J Food Microbiol 2009, 128:453-459. 10.1016/j.ijfoodmicro.2008.10.014, 18996610.
16. Ye JX, Kostrzynska M, Dunfield K, Warriner K. Evaluation of a biocontrol preparation consisting of Enterobacter asburiae JX1 and a lytic bacteriophage cocktail to suppress the growth of Salmonella javiana associated with tomatoes. J Food Prot 2009, 72:2284-2292.
17. Wall SK, Zhang J, Rostagno MH, Ebner PD. Phage therapy to reduce preprocessing Salmonella infections in market-weight swine. Appl Environ Microbiol 2010, 76:48-53. 10.1128/AEM.00785-09, 2798657, 19854929.
18. Padukone N, Peretti SW, Ollis DF. λ vectors for stable cloned gene expression. Biotechnol Prog 1990, 6:277-282. 10.1021/bp00004a008, 1368559.
19. Westwater C, Schofield DA. Phage as vectors and targeted delivery vehicles. Bacteriophages: biology and applications 2005, 297-320. Boca Raton: CRC Press, Kutter E, Sulakvedize A.
20. Oh JS, Choi SS, Yeo JK, Park TH. Construction of various bacteriophage λ mutants for stable and efficient production of recombinant protein in Escherichia coli. Process Biochem 2007, 42:486-490.
21. Bhattacharya S, Chakrabarti S, Navak A, Bhattacharya SK. Metabolic networks of microbial systems. Microb Cell Fact 2003, 2:3. 10.1186/1475-2859-2-3, 155636, 12740044.
22. Barbas CF, Burton DR, Scott JK, Silverman GJ. Phage display: A laboratory manual. 2004, Cold Spring Harbor: Cold Spring Harbor Laboratory Press.
23. Dickerson TJ, Kaufmann GF, Janda KD. Bacteriophage-mediated protein delivery into the central nervous system and its application in immunopharmacotherapy. Expert Opin Biol Ther 2005, 5:773-781. 10.1517/14712598.5.6.773, 15952908.
24. Mattanovich D, Borth N. Applications of cell sorting in biotechnology. Microb Cell Fact 2006, 5:12. 10.1186/1475-2859-5-12, 1435767, 16551353.
25. Pajtasz-Piasecka E, Rossowska J, Duoe D, Weber-Dabrowska B, Zabocka A, Gorski A. Bacteriophages support anti-tumor response initiated by DC-based vaccine against murine transplantable colon carcinoma. Immun Lett 2008, 116:24-32.
26. Sinkovics JG, Horvath JC. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers. Arch Immunol Ther Exp 2008, 56:3-59.
27. Suchanova B, Tuma R. Folding and assembly of large macromolecular complexes monitored by hydrogen-deuterium exchange and mass spectrometry. Microb Cell Fact 2008, 7:12. 10.1186/1475-2859-7-12, 2365927, 18394161.
28. Lee TJ, Schwartz C, Guo P. Construction of bacteriophage Phi29 DNA packaging motor and its applications in nanotechnology and therapy. Ann Biomed Eng 2009, 37:2064-2081. 10.1007/s10439-009-9723-0, 2855900, 19495981.
29. Wolcott R, Rhoads D, Kuskowski M, Ward L, Sulakvelidze A. Bacteriophage therapy of venous leg ulcers in humans: results of a Phase I safety trial. J Wound Care 2009, 18:231-243.
30. Villaverde A. Nanotechnology, nanobiotechnology and microbial cell factories. Microb Cell Fact 2010, 9:53. 10.1186/1475-2859-9-53, 2916890, 20602780.
31. Sargeant K, Yeo KG, Lethbridge JH, Shooter KV. Production of bacteriophage T7. Appl Microbiol 1968, 16:1483-1488. 547689, 4879212.
32. Chen BY, Lim HC. Bioreactor studies on temperature induction of the Q-mutant of bacteriophage λ in Escherichia coli. J Biotechnol 1996, 51:1-20. 10.1016/0168-1656(96)01571-4, 8987627.
33. Clark DW, Meyer H-P, Leist C, Fiechter A. Effects of growth medium on phage production and induction in Escherichia coli K-12 lambda lysogens. J Biotechnol 1986, 3:271-280.
34. Park SH, Park TH. Analysis of two-stage continuous operation of Escherichia coli containing bacteriophage λ vector. Bioprocess Eng 2000, 23:187-190.
35. Los M, Wegrzyn G, Neubauer P. A role for bacteriophage T4 rI gene function in the control of phage development during pseudolysogeny and in slow growing host cells. Res Microbiol 2003, 154:547-552. 10.1016/S0923-2508(03)00151-7, 14527655.
36. Chen XA, Cen PL. A novel three-stage process for continuous production of penicillin G acylase by a temperature-sensitive expression system of Bacillus subtilis phage phi105. Chem Biochem Quart 2005, 19:367-372.
37. Oh JS, Cho D, Park TH. Two-stage continuous operation of recombinant Escherichia coli using the bacteriophage λ Q-vector. Bioprocess Biosys Eng 2005, 28:1-7.
38. Park TH, Seo JH, Lim HC. Two-stage fermentation with bacteriophage λ as an expression vector in Escherichia coli. Biotechnol Bioeng 1991, 37:297-302. 10.1002/bit.260370402, 18597370.
39. Horne MT. Coevolution of Escherichia coli and bacteriophages in chemostat culture. Science 1970, 168:992-993. 10.1126/science.168.3934.992-a, 4909622.
40. Levin BR, Stewart FM, Chao L. Resource-limited growth, competition, and predation: a model and experimental studies with bacteria and bacteriophage. Am Nat 1977, 111:3-24.
41. Lenski RE, Levin BR. Constraints on the coevolution of bacteria and virulent phage: a model, some experiments, and predictions for natural communities. Am Nat 1985, 125:585-602.
42. Bohannan BJM, Lenski RE. Effect of resource enrichment on a chemostat community of bacteria and bacteriophage. Ecology 1997, 78:2303-2315.
43. Buckling A, Rainey PB. Antagonistic coevolution between a bacterium and a bacteriophage. Proc R Soc Lond B-Biol Sci 2002, 269:931-936.
44. Mizoguchi K, Morita M, Fischer CR, Yoichi M, Tanji Y, Unno H. Coevolution of bacteriophage PP01 and Escherchia coli O157:H7 in continuous culture. Appl Environ Microbiol 2003, 69:170-176. 10.1128/AEM.69.1.170-176.2003, 152390, 12513992.
45. Forde SE, Thompson JN, Bohannan BJM. Adaptation varies through space and time in a coevolving host-parasitoid interaction. Nature 2004, 431:841-844. 10.1038/nature02906, 15483611.
46. Kloppinger M, Fertig G, Fraune E, Miltenburger HG. Multistage production of Autographa californica nuclear polyhedrosis virus in insect cell cultures. Cytotech 1990, 4:271-278.
47. Zhang J, Kalogerakis N, Behie LA, Iatrou K. A two-stage bioreactor system for the production of recombinant protein using a genetically engineered baculovirus/insect cell system. Biotech Bioeng 1993, 42:357-366.
48. van Lier FLJ, van den Hombergh JPTW, de Gooijer CD, den Boer MM, Vlak JM, Tramper J. Long-term semi-continuous production of recombinant baculovirus protein in a repeated (fed-)batch two-stage reactor system. Enzyme Microb Tech 1996, 18:460-466.
49. Sheppard JD, Cooper DG. Development of computerized feedback control for the continuous phasing of Bacillus subtilis. Biotech Bioeng 1990, 36:539-545.
50. Brown WA, Cooper DG. Self-cycling fermentation applied to Acinetobacter calcoaceticus RAG-1. Appl Environ Microbiol 1991, 57:2901-2906. 183894, 16348564.
51. McCaffrey WC, Cooper DG. Sophorolipids production by Candida bombicola using self-cycling fermentation. J Ferm Bioeng 1994, 79:146-151.
52. Sarkis BE, Cooper DG. Biodegradation of aromatic compounds in a self-cycling fermenter (SCF). Can J Chem Eng 1996, 72:874-880.
53. Marchessault P, Sheppard JD. Application of self-cycling fermentation technique to the production of poly-β-hydroxybutyrate. Biotech Bioeng 1997, 55:815-820.
54. Sauvageau D, Storms Z, Cooper DG. Synchronized populations of Escherichia coli using simplified self-cycling fermentation. J Biotech 2010, 149:67-73.
55. Bull JJ. Patterns in phage experimental adaptation. Bacteriophage Ecology: Population Growth, Evolution and Impact of Bacterial Viruses 2008, 217-247. Cambridge: Cambridge University Press, Abedon ST.
56. Sauvageau D, Allain B, Cooper DG. Using the rate of respiration to monitor events in the infection of Escherichia coli cultures by bacteriophage T4. Biotech Progress 2010, 26:865-871.
57. Maniatis T, Sambrook J, Fritsch EF. Molecular cloning: a laboratory manual 1989, Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 2.
58. Asami K, Xing XH, Tanji Y, Unno H. Synchronized disruption of Escherichia coli cells by T4 phage infection. J Ferm Bioeng 1997, 83:511-516.
59. Rabinovitch A, Hadas H, Einav M, Melamed Z, Zaritsky A. Model for bacteriophage T4 development in Escherichia coli. J Bacteriol 1999, 181:1677-1683. 93561, 10049403.